We are live on ! Find out more
Geode Capital Management

Geode Capital Management Portfolio holdings

AUM $1.88T
1-Year Est. Return 44.46%
 

Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.

This Fund
S&P 500
This Quarter Est. Return
+0.67%
1 Year Est. Return
+44.46%
3 Year Est. Return
+136.69%
5 Year Est. Return
+180.19%
10 Year Est. Return
+697.06%
AUM
$743B
AUM Growth
+$17B
Cap. Flow
+$20.9B
Cap. Flow %
2.82%
Top 10 Hldgs %
22.73%
Holding
4,944
New
223
Increased
2,961
Reduced
1,210
Closed
86

Top Buys

Rank Stock Value
1
MRNA icon
Moderna
MRNA
+$887M
2
AMZN icon
Amazon
AMZN
+$857M
3
AAPL icon
Apple
AAPL
+$844M
4
MSFT icon
Microsoft
MSFT
+$802M
5
TSLA icon
Tesla
TSLA
+$606M

Sector Composition

Rank Sector Weight
1 Technology 24.53%
2 Financials 13.97%
3 Healthcare 13.42%
4 Consumer Discretionary 11.85%
5 Communication Services 10.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PLBC icon
3726
Plumas Bancorp
PLBC
$442M
$922K ﹤0.01%
29,460
+14,783
+101% +$473K
SBFG icon
3727
SB Financial Group
SBFG
$171M
$918K ﹤0.01%
53,272
+3,746
+8% +$65.1K
SREV
3728
DELISTED
ServiceSource International, Inc.
SREV
$915K ﹤0.01%
678,163
+57,391
+9% +$83.6K
ABEO icon
3729
Abeona Therapeutics
ABEO
$361M
$912K ﹤0.01%
32,597
+6,316
+24% +$202K
SRZN icon
3730
Surrozen
SRZN
$279M
$910K ﹤0.01%
+8,569
New +$1.21M
BCLI
3731
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
$909K ﹤0.01%
18,383
+707
+4% +$37.2K
SNCR
3732
DELISTED
Synchronoss Technologies
SNCR
$907K ﹤0.01%
42,036
+2,614
+7% +$64.2K
AG icon
3733
First Majestic Silver
AG
$9.26B
$902K ﹤0.01%
79,679
+11,531
+17% +$149K
AFYA icon
3734
Afya
AFYA
$1.23B
$901K ﹤0.01%
45,674
+240
+0.5% +$5.44K
LPCN icon
3735
Lipocine
LPCN
$17M
$898K ﹤0.01%
48,496
+3,756
+8% +$82.9K
TACT icon
3736
Transact Technologies
TACT
$52.5M
$898K ﹤0.01%
64,676
+20,274
+46% +$288K
OKUR
3737
OnKure Therapeutics
OKUR
$158M
$898K ﹤0.01%
12,067
+4,860
+67% +$412K
WPP icon
3738
WPP
WPP
$5.82B
$897K ﹤0.01%
13,389
+174
+1% +$11.7K
MN
3739
DELISTED
MANNING & NAPIER, INC.
MN
$897K ﹤0.01%
98,333
+5,481
+6% +$49.6K
FONR
3740
DELISTED
Fonar
FONR
$895K ﹤0.01%
57,922
-667
-1% -$11.3K
UBFO
3741
DELISTED
United Security Bancshares
UBFO
$892K ﹤0.01%
111,584
+4,952
+5% +$39.9K
MARK
3742
DELISTED
Remark Holdings, Inc.
MARK
$892K ﹤0.01%
84,961
+6,219
+8% +$81.5K
AOMR
3743
Angel Oak Mortgage REIT
AOMR
$209M
$891K ﹤0.01%
+52,680
New +$936K
FUNC icon
3744
First United
FUNC
$298M
$889K ﹤0.01%
47,813
+695
+1% +$12.3K
TELA icon
3745
TELA Bio
TELA
$30.4M
$886K ﹤0.01%
64,923
+824
+1% +$11.5K
WIT icon
3746
Wipro
WIT
$19.4B
$886K ﹤0.01%
200,890
-9,332
-4% -$40.8K
ALOT icon
3747
AstroNova
ALOT
$227M
$884K ﹤0.01%
58,783
MRIN
3748
DELISTED
Marin Software
MRIN
$881K ﹤0.01%
16,103
+5,633
+54% +$279K
TUSK icon
3749
Mammoth Energy Services
TUSK
$154M
$880K ﹤0.01%
302,684
-7,685
-2% -$27.4K
PHAS
3750
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
$872K ﹤0.01%
280,589
+84,729
+43% +$283K

Similar funds

Geode Capital Management's Q3 2021 Portfolio in Review

As of Q3 2021, Geode Capital Management held 4,944 positions worth $743B, up 2.3% from $726B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Geode Capital Management's Q3 2021 filing shows 223 new, 2,961 increased, 1,210 reduced and 86 closed positions. Its largest new stake was Lucid Motors: 565,353 shares worth $143M. The largest sale was Alexion Pharmaceuticals, an estimated $760M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.

  • Geode Capital Management's largest Q3 2021 buy was Lucid Motors: 565,353 shares worth $143M.
  • Geode Capital Management added most to Moderna in Q3 2021, an estimated $887M increase.
  • Geode Capital Management's biggest Q3 2021 reduction was Oracle, cutting an estimated $126M.
  • Geode Capital Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $760M.
  • Geode Capital Management's ten largest holdings make up 23% of its $743B portfolio in Q3 2021.
  • Geode Capital Management opened 223 new positions and closed 86 in Q3 2021.
  • Geode Capital Management's portfolio value rose 2.3% quarter-over-quarter to $743B.

Based on Geode Capital Management's 13F filing for Q3 2021, filed 12 Nov 2021.